Psyched: Investment Banks Bullish On Atai Life Sciences, Wesana’s $17M Purchase Of PsyTech, Creso Pharma Acquires Halucenex
A number of financial firms and investment banks initiated coverage of Atai Life Sciences (NASDAQ: ATAI) last week.
Psyched: Atai’s $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers
Atai Launches $214 Million Nasdaq IPO Offering
Psychedelics biotech platform Atai life Sciences has announced an initial public offering of approximately 14 million of its common shares, ahead of the company’s expected Nasdaq listing.
Red Light Holland Buys Virtual Reality Company And Majority Stake In Grow-At-Home Mushroom Company
Red Light Holland Corp. (Canadian: TRIP) (OTC Pink: TRUFF), a company looking at recreational markets in the psychedelics space, closed two major acquisitions this week.
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
Cannabis stocks traded mostly in the green this week, as we got into earnings season.